Crossmark

Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study

Crossref DOI link: https://doi.org/10.1186/s12890-015-0037-8

Published Online: 2015-05-14

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kimura, Mai

Tamura, Yuichi

Takei, Makoto

Yamamoto, Tsunehisa

Ono, Tomohiko

Fujita, Jun

Kataoka, Masaharu

Kuwana, Masataka

Satoh, Toru

Fukuda, Keiichi
License Information

License valid from 2015-05-14
More Information

Article History

Received: 6 January 2015

Accepted: 15 April 2015

First Online: 14 May 2015